Kolexia
Azzedine Ahmed
Médecine interne
Hôpital Portes de Provence
Montélimar, France
53 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs colorectales Adénocarcinome Tumeurs du côlon Métastase tumorale Tumeurs de l'estomac Tumeurs du rectum Tumeurs du pancréas Douleur chronique Fatigue

Industries

AstraZeneca
8 collaboration(s)
Dernière en 2023
MSD
7 collaboration(s)
Dernière en 2023
B3TSI
6 collaboration(s)
Dernière en 2023
Lilly
6 collaboration(s)
Dernière en 2023

Dernières activités

DONEPEZOX: Evaluation of the Efficacy of Donepezil in the Treatment of Oxaliplatin-induced Peripheral Neuropathy: Proof of Concept Study
Essai Clinique (CHU Clermont-Ferrand)   25 avril 2023
AURAL-STILL: Auvergne-Rhône-Alpes-Limousin Research Database for Still's Diseases in Children and Adults
Essai Clinique (Hospices Civils de Lyon)   14 septembre 2021
Pôle oncologie de l'hôpital de Montélimar : « Le vrai traitement du ...
Le Dauphiné   04 février 2021
Brief Hospital Supervision of Exercise and Diet During Adjuvant Breast Cancer Therapy Is Not Enough to Relieve Fatigue: A Multicenter Randomized Controlled Trial.
Nutrients   09 octobre 2020
Quality of life and cost of strategies of two chemotherapy lines in metastatic colorectal cancer: results of the FFCD 2000-05 trial.
Expert review of pharmacoeconomics & outcomes research   15 février 2019
Prognostic factors in patients treated with second-line chemotherapy for advanced gastric cancer: results from the randomized prospective phase III FFCD-0307 trial.
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association   11 octobre 2018
Combination Chemotherapy as First-Line Therapy in Treating Older Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery: Randomized Study of Classic vs Simplified Leucovorin Calcium and Fluorouracil With or Without Irinotecan in Patients Aged At Least 75 Years With Advanced Colorectal Cancer
Essai Clinique (Fédération Francophone de Cancérologie Digestive)   27 mai 2016
Randomized phase III trial in elderly patients comparing LV5FU2 with or without irinotecan for first-line treatment of metastatic colorectal cancer (FFCD 2001-02).
Annals of oncology : official journal of the European Society for Medical Oncology   20 octobre 2015
Trial Comparing Two Strategies of Chemotherapy for Metastatic Colorectal Cancer: Randomized Trial of Treatment Strategy for Chemotherapy in Colorectal Cancer, FFCD 2000-05
Essai Clinique (Sanofi)   11 août 2015
Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset.
Annals of oncology : official journal of the European Society for Medical Oncology   25 juin 2015